CMSC 2021: Top Interviews and Key Takeaways

The NeurologyLive® team has compiled a roundup of our discussions with leaders in the multiple sclerosis field following the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC).

The 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), October 25-28, was held in a hybrid format, with experts in the field of multiple sclerosis (MS) convening in Orlando, Florida, as well as virtually, to discuss the latest advances, ongoing developments, and future direction of research.

Presentations covered a breadth of subjects within the MS space, including disease-modifying therapies (DMTs) and interaction with available COVID-19 vaccines, a trial developed to address the lack of representation of minority populations in MS clinical trials, and the integration of registered dietitians and wellness programs for this patient population. Swipe through the slideshow below to browse our interviews with experts, both on-site and virtually, and be sure to check back for ongoing coverage from the conference. 

——————————————————

Click here for more coverage of multiple sclerosis from NeurologyLive®, or for more coverage of CMSC 2021, click here

REFERENCE
1. Wattjes MP, Ciccarelli O, Reich DS, et al; 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021;20(8):653-670. doi:10.1016/S1474-4422(21)00095-8